Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

A fructose transporter (GLUT 5) as a target for breast cancer therapy and imaging

Dissertation (MSc)--University of Pretoria, 2013.

Saved in:
Bibliographic Details
Other Authors: Cromarty, Allan Duncan
Format: Thesis
Published: University of Pretoria 2013
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867613615424536576
access_status_str Open Access
author2 Cromarty, Allan Duncan
author_browse Cromarty, Allan Duncan
author_facet Cromarty, Allan Duncan
collection Thesis
dc_rights_str_mv © 2012, University of Pretoria. All rights reserved. The copyright in this work vests in the University of Pretoria. No part of this work may be reproduced or transmitted in any form or by any means, without the prior written permission of the University of Pretoria
description Dissertation (MSc)--University of Pretoria, 2013.
format Thesis
id oai:repository.up.ac.za:2263/29737
institution University of Pretoria (South Africa)
last_indexed 2026-06-10T12:38:57.791Z
license_str Other — see source repository
provenance_str_mv Harvested via OAI-PMH from UPSpace — University of Pretoria Institutional Repository
publishDate 2013
publishDateRange 2013
publishDateSort 2013
publisher University of Pretoria
publisherStr University of Pretoria
record_format dspace
source_str UPSpace — University of Pretoria Institutional Repository
spelling oai:repository.up.ac.za:2263/29737 A fructose transporter (GLUT 5) as a target for breast cancer therapy and imaging Cromarty, Allan Duncan kyamunigy@yahoo.fr Kyalangalilwa, Mulondani Nicolas Breast cancer Glut 5 Therapy UCTD Dissertation (MSc)--University of Pretoria, 2013. Introduction: Positron Emission Tomography (PET) has revolutionized the diagnostic and imaging fields in cancer research. PET has opened new avenues in the pre-clinical study of radiotracers and radio-therapeutic compounds of which the full potentials are yet to be explored. To date 18F-Fluoro-Deoxy-Glucose1 (18F-FDG) is the most widely used radiotracer for PET imaging. The success of 18F-FDG is due to the existence of several trans-membrane proteins responsible for the facilitated transport of glucose. A related protein is a specific fructose selective trans-membrane transporter (GLUT 5) that has been observed to be over-expressed by some types of cancer cells suggesting that D-fructose is utilized by these cancer cells for energy production. Thus labeled D-fructose derivatives are potential candidates for selective PET imaging for cancer cells similar to 18F-FDG in active cells. Aim: The aim of this study was to investigate the effect of D-fructose on GLUT 5 positive and negative cell cultures and to evaluate the feasibility of GLUT 5 as a target for PET imaging of breast cancer. Objectives: The following were investigated: <ul> i. The extent of expression of GLUT 5 in three cancer cell lines: breast cancer cells (MCF-7), Baby Hamster Kidney cells (BHK) and cervical epithelial carcinoma cells (Hela). ii. The colony formation potential of D-fructose enriched medium (glucose-free) and its effect on proliferation of the investigated cell lines. iii. The effect of anti-GLUT 5 antibodies on the proliferation of breast cancer cells in vitro. iv. The synthesis and characterization of a non-radioactive fluorinated D-fructose derivative (1-deoxy-fluoro–D-fructose) </ul> Results: D-fructose was observed to mediate cell growth in MCF-7 cell lines but not in Hela and BHK cell lines. Glucose stimulated significantly greater cell proliferation than D-fructose for all 3 cell lines but more noticeably for the Hela (p<0.001) and BHK (p=0.0110) cell lines at all tested concentrations. Cell growth of MCF-7 cell lines where only D-fructose was present suggests a role for the highly expressed fructose specific transporter (GLUT 5) in the use of D-fructose for energy production and cell growth by these breast cancer cells. No significant differences were observed in the ability of D-fructose enriched medium to induce 3D colony formation among the three cell lines studied (p>0.05) suggesting that D-fructose is not linked directly with aggressive carcinogenesis in these cell lines despite the observed evidence of D-fructose involvement in cell proliferation and energy consumption. Anti-GLUT 5 antibodies did not show an inhibitory effect on MCF-7 cell proliferation at concentration up to 1 μg/ml (1:1000) despite these cells high expression of GLUT 5. GLUT 5 is highly expressed by MCF-7 but not by Hela and BHK cell lines making it an important selective target for imaging of this type of breast cancer and a possible therapeutic target for antibody targeted therapy of breast cancer. A chemical reaction sequence for the synthesis of 1-deoxy-fluoro–D-fructose (1-FDF) was carried out and an acceptable yield for an isotope labeling friendly reaction sequence was obtained and the product chemically characterized. Conclusion: The D-fructose transporter GLUT 5 shows potential for possible application with PET imaging of breast cancer. Isotope labeled 1-FDF can be synthesized in good yield and should be the object of further studies such as development of an automated synthesis module for its radio-labeled derivative as well as pre-clinical animal and human studies. Copyright Pharmacology unrestricted 2013-09-07T16:27:00Z 2013-01-07 2013-09-07T16:27:00Z 2012-09-07 2013-01-07 2012-11-23 Dissertation Kyalangalilwa, MN 2012, A fructose transporter (GLUT 5) as a target for breast cancer therapy and imaging, MSc dissertation, University of Pretoria, Pretoria, viewed yymmdd < http://hdl.handle.net/2263/29737 > E12/9/198/gm http://hdl.handle.net/2263/29737 http://upetd.up.ac.za/thesis/available/etd-11232012-185912/ © 2012, University of Pretoria. All rights reserved. The copyright in this work vests in the University of Pretoria. No part of this work may be reproduced or transmitted in any form or by any means, without the prior written permission of the University of Pretoria application/pdf University of Pretoria
spellingShingle Breast cancer
Glut 5
Therapy
UCTD
A fructose transporter (GLUT 5) as a target for breast cancer therapy and imaging
title A fructose transporter (GLUT 5) as a target for breast cancer therapy and imaging
title_full A fructose transporter (GLUT 5) as a target for breast cancer therapy and imaging
title_fullStr A fructose transporter (GLUT 5) as a target for breast cancer therapy and imaging
title_full_unstemmed A fructose transporter (GLUT 5) as a target for breast cancer therapy and imaging
title_short A fructose transporter (GLUT 5) as a target for breast cancer therapy and imaging
title_sort fructose transporter glut 5 as a target for breast cancer therapy and imaging
topic Breast cancer
Glut 5
Therapy
UCTD
url http://hdl.handle.net/2263/29737
http://upetd.up.ac.za/thesis/available/etd-11232012-185912/